Rasburicase Injection

Product Details:

Application Other
Storage Instructions Keep at cool and dry place
Share Your Product:

Get a Price/Quote

Request To Call Back Send Inquiry

Rasburicase Injection Price And Quantity

Rasburicase Injection Product Specifications

Application Other
Storage Instructions Keep at cool and dry place

Rasburicase Injection Trade Information

Main Export Market(s) Australia North America South America Eastern Europe Western Europe Middle East Africa Asia Central America
Main Domestic Market All India

Product Description

Rasburicase Injection has been formulated to be administered for treatment of tumor lysis syndrome induced due to chemotherapy for leukemia & lymphomas. It is known to work by removing uric acid from blood by oxidizing it and converting into poorly soluble form. This injection shows no bioavailability with elimination half life of about 18hours. It is a tetrameric protein which is considered to be effective for ovarian cancer and hemorrhagic cystitis. Rasburicase Injection is administered via intravenous route by experienced physician or nurse. It is known to take around 4 hours for lowering plasma uric acid levels below 7.5 mg/dl.

Product Details:

Minimum Order Quantity - 1000 Unit

Usage - Commercial, Clinical, Hospital

We are leading exporter and manufacturer of Rasburicase Injection.

Uses

Rasburicase is used in the treatment of ovarian cancer, blood cancer, hemorrhagic cystitis and methotrexate toxicity.

How it works

Rasburicase, a urate-oxidase enzyme, works by eliminating the excess uric acid that is produced when cancer cells are destroyed.

Common side effects

Nausea, Headache, Vomiting, Rash, Urticaria, Fever, Diarrhea

Tag

Rasburicase Injection exporter, Rasburicase Injection manufacturer